News ArchivesRead News
How A Single Protein Could Unlock New Treatments For Brain Cancer And Parkinson's Disease
Tuesday July 15, 2014
Medical Daily - The same protein that keeps neurons alive and healthy also gives cancer cells the longevity to grow and spread, a team of researchers said Tuesday.
The University of North Carolina announced the new findings, which are published in the journal Science Signaling, saying, "brain cancer cells hijack the same mechanism for their own survival." While the research could lead to breakthroughs in brain cancer, it also could provide fresh insight into the way Parkinson's disease destroys brain cells. Their results may spawn new treatment methods against the second most prevalent neurodegenerative disease, after Alzheimer's.
What the scientists discovered is that a little-understood protein called PARC/CUL9, or PARC for short, is a main inhibitor of cell death in the brain. Every cell has a powerhouse called the mitochondria. When mitochondria malfunction, they release a chemical that begins the process of killing the cell.
To study this process, called apoptosis, Vivian Gama, a co-author of the study, synthetically damaged mitochondria in the brains of mice. Neurons are resilient; as apoptosis kicked in, the cells manufactured the protein, PARC, that works like an elixir. It degrades the chemical that causes the cell to self-destruct, thereby extending its lifespan. For neurons, this is a critical function, allowing us to think clearly into old age.
It's easy to imagine harnessing the protein to help people — or at least brains — live forever. But for now, the researchers are concerned with fighting two diseases linked to PARC. Parkinson's is caused by the degradation of a part of the brain responsible for motor control and the production of dopamine. PARC, they noticed, is similar to Parkin, which mutates the mitochondria in Parkinson's patients, said Mohanish Deshmukh, a UNC cell biologist who co-authored the paper, in a statement. "We think they might work in tandem to protect neurons." Keeping both PARC and Parkin working normally may be the key to reversing the disease.
Gama and her colleagues tested what would happen when they inhibited the production of PARC in a particular kind of cancer cells. As expected, they "were more vulnerable to stress and damage," but not completely. "Not all cytochrome c [the apoptosis chemical] is degraded," Gama says. "There are likely other factors involved."
Wolford, Ben. (15 July 2014). Medical Daily. How A Single Protein Could Unlock New Treatments For Brain Cancer And Parkinson's Disease. http://www.medicaldaily.com/how-single-protein-could-unlock-new-treatments-brain-cancer-and-parkinsons-disease-293016
Recent NewsSep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement